FCH
BMY icon

Freestone Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Freestone Capital Holdings’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$644K Buy
10,612
+716
+7% +$41.7K 0.02% 306
2025
Q4 		$534K Sell
9,896
-756
-7% -$36.4K 0.02% 324
2025
Q3 		$480K Sell
10,652
-8,836
-45% -$413K 0.01% 353
2025
Q2 		$902K Buy
19,488
+3,855
+25% +$189K 0.03% 234
2025
Q1 		$953K Sell
15,633
-32,331
-67% -$1.88M 0.04% 219
2024
Q4 		$2.71M Sell
47,964
-30,906
-39% -$1.73M 0.09% 138
2024
Q3 		$4.08M Buy
78,870
+31,738
+67% +$1.49M 0.14% 111
2024
Q2 		$1.96M Sell
47,132
-9,454
-17% -$423K 0.07% 164
2024
Q1 		$3.07M Sell
56,586
-4,767
-8% -$243K 0.11% 128
2023
Q4 		$3.15M Sell
61,353
-5,188
-8% -$272K 0.14% 115
2023
Q3 		$3.86M Buy
66,541
+2,209
+3% +$135K 0.2% 84
2023
Q2 		$4.11M Buy
64,332
+307
+0.5% +$20.6K 0.17% 90
2023
Q1 		$4.44M Sell
64,025
-2,877
-4% -$203K 0.2% 80
2022
Q4 		$4.81M Sell
66,902
-17,047
-20% -$1.29M 0.22% 75
2022
Q3 		$5.97M Sell
83,949
-17,221
-17% -$1.25M 0.27% 61
2022
Q2 		$7.79M Sell
101,170
-19,017
-16% -$1.45M 0.3% 52
2022
Q1 		$8.78M Sell
120,187
-1,821
-1% -$122K 0.35% 61
2021
Q4 		$7.61M Buy
122,008
+1,460
+1% +$85.6K 0.32% 68
2021
Q3 		$7.13M Buy
120,548
+1,575
+1% +$104K 0.36% 63
2021
Q2 		$7.95M Sell
118,973
-25,059
-17% -$1.63M 0.4% 59
2021
Q1 		$9.09M Sell
144,032
-1,817
-1% -$113K 0.49% 46
2020
Q4 		$9.05M Buy
145,849
+17,245
+13% +$1.06M 0.53% 37
2020
Q3 		$7.75M Buy
128,604
+591
+0.5% +$35.6K 0.51% 41
2020
Q2 		$7.53K Buy
128,013
+8,213
+7% +$491K 0.09% 50
2020
Q1 		$6.68K Sell
119,800
-5,132
-4% -$314K 0.14% 51
2019
Q4 		$8.02K Sell
124,932
-16,835
-12% -$964K 0.17% 41
2019
Q3 		$7.19K Buy
141,767
+31,948
+29% +$1.5M 0.17% 47
2019
Q2 		$4.98K Buy
+109,819
New +$5.12M 0.13% 106
2018
Q1 		– Sell
-3,463
Closed -$212K – 339
2017
Q4 		$212K Sell
3,463
-238
-6% -$14.9K 0.01% 323
2017
Q3 		$236K Buy
+3,701
New +$216K 0.02% 308

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Freestone Capital Holdings's BMY Position: Q1 2026 in Review

Freestone Capital Holdings increased its Bristol-Myers Squibb (BMY) stake by 7.2% in Q1 2026, buying an estimated $41.7K and bringing the position to 10,612 shares worth $644K. The position accounts for 0.02% of the portfolio, ranked #306.

Freestone Capital Holdings first reported a position in BMY in Q3 2017 and has held it in 30 quarters since. The position peaked at $9.09M in Q1 2021. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Freestone Capital Holdings held 10,612 shares of Bristol-Myers Squibb worth $644K as of Q1 2026.
  • Freestone Capital Holdings bought 716 Bristol-Myers Squibb shares in Q1 2026, an estimated $41.7K.
  • Bristol-Myers Squibb made up 0.02% of Freestone Capital Holdings's portfolio in Q1 2026, its #306 holding.
  • Freestone Capital Holdings first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 30 quarters since.
  • Freestone Capital Holdings's Bristol-Myers Squibb position peaked at $9.09M in Q1 2021.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.